INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

20,303 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$183K
306 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

Page 8 of 508
← PrevNext →
12
TF
Tan FionaChief Technology Officer
WWayfair Inc.
Open-market sale · 10b5-1 plan
SELL
$859K
7,000 sh
Nov 5, 2026
Nov 6, 2026
traded Nov 5, 2026
+1d
SEC Form 4

Evidence

12
BP
Buckley Sean PatrickSee Remarks
MGNIMAGNITE, INC.
Open-market sale · 10b5-1 plan
SELL$297K
11.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

12
DB
Dempsey Tyler BGeneral Counsel
RPAYRepay Holdings Corp
Open-market sale · 10b5-1 plan
SELL$119K
25.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

12
RH
Rubenstein Andrew H.Director, 10% Owner, Chairman
ACELAccel Entertainment, Inc.
Open-market sale · 10b5-1 plan
SELL$518K
40.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

12
JK
Johnson Sandra K.Director
RMRegional Management Corp.
Open-market sale · 10b5-1 plan
SELL$77K
2,009 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

11
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$432K
2,101 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

11
MA
Maheshwari AnshulChief Op & Financial Officer
SIBNSI-BONE, Inc.
Open-market sale · 10b5-1 plan
SELL$81K
3,247 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

11
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$600K
2,900 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

11
FF
Fraga FranciscoEVP, CIO and CTO
MCKMCKESSON CORP
Open-market sale · 10b5-1 plan
SELL$717K
650 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

11
MD
Mansueto Joseph DDirector, Executive Chairman, 10% Owner
MORNMorningstar, Inc.
Open-market sale · 10b5-1 plan
SELL$467K
1,896 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

11
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$317K
1,500 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

11
MD
Mansueto Joseph DDirector, Executive Chairman, 10% Owner
MORNMorningstar, Inc.
Open-market sale · 10b5-1 plan
SELL$724K
2,932 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

11
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$794K
3,773 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

11
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$523K
2,502 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

11
AR
Altschuler RandolphDirector
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$259K
2,358 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

11
MD
Mansueto Joseph DDirector, Executive Chairman, 10% Owner
MORNMorningstar, Inc.
Open-market sale · 10b5-1 plan
SELL$557K
2,248 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

11
PJ
Peters William JDirector, CFO, EVP & TREASURER
AMPHAmphastar Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$366K
12.6K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

11
ZM
Zerbe Robert L MdDirector
VCELVericel Corp
Open-market sale · 10b5-1 plan
SELL$28K
500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

11
PC
Pitigoi CosminChief Financial Officer
FLYWFlywire Corp
Open-market sale · 10b5-1 plan
SELL$15K
700 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

10
TP
Taffe Norman PPresident Generac Home
GNRCGENERAC HOLDINGS INC.
Open-market sale · 10b5-1 plan
SELL$18K
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

10
SS
Skates SpenserDirector, CEO and President, 10% Owner
AMPLAmplitude, Inc.
Open-market sale · 10b5-1 plan
SELL$597
32 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

10
DP
DIRK VAN DE PUTDirector, Chief Executive Officer
MDLZMondelez International, Inc.
Open-market sale · 10b5-1 plan
SELL$1.42M
20.9K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

10
SR
Szczepaniak Mark RChief Financial Officer
VELVelocity Financial, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
2,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

10
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$47K
80 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

10
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$24K
40 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

10
WY
Wang YanjunCCO and GC
SESea Ltd
Open-market sale · 10b5-1 plan
SELL$5,080
64 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

10
VJ
Vassil JonathanChief Revenue Officer
TOSTToast, Inc.
Open-market sale · 10b5-1 plan
SELL$166K
4,600 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

10
SS
Skates SpenserDirector, CEO and President, 10% Owner
AMPLAmplitude, Inc.
Open-market sale · 10b5-1 plan
SELL$16K
901 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

10
WY
Wang YanjunCCO and GC
SESea Ltd
Open-market sale · 10b5-1 plan
SELL$19K
236 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

10
TP
Taffe Norman PPresident Generac Home
GNRCGENERAC HOLDINGS INC.
Open-market sale · 10b5-1 plan
SELL$36K
200 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

10
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$5,998
10 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

10
OP
O'Day Daniel PatrickDirector, Chairman & CEO
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$1.72M
9,810 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

10
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$46K
80 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

10
WY
Wang YanjunCCO and GC
SESea Ltd
Open-market sale · 10b5-1 plan
SELL$41K
500 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

10
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$48K
80 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
BD
Buonasera DavidCHIEF TECHNOLOGY OFFICER
MGNIMAGNITE, INC.
Open-market sale · 10b5-1 plan
SELL$115K
4,272 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

8
AR
Altschuler RandolphDirector
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$132K
1,261 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

8
AR
Altschuler RandolphDirector
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$123K
1,097 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

8
TS
Tamari ShaharDirector, COO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$12K
271 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence